Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial - Bunnapradist, S; Ciechanowski, K; West-Thielke, PMELT investigators (Am J Transplant, 2013)
et al.;